The Home Infusion Therapy Market has demonstrated robust growth, valued at USD 36 billion in 2023. Forecasts indicate a substantial increase, with expectations reaching USD 66.63 billion by 2031. This growth is attributed to several factors, including the rising prevalence of chronic diseases, advancements in infusion therapy technologies, and a shift towards home-based healthcare solutions. With an anticipated compound annual growth rate (CAGR) of 8% during the forecast period from 2024 to 2031, the market is poised for significant expansion, driven by the growing demand for convenient and cost-effective treatment options, coupled with efforts to improve patient outcomes and quality of life.